Tata Medical and Diagnostics (Tata MD), the new healthcare venture of the Tata group, recently launched ‘The New Standard in COVID Testing’ – TataMD CHECK – across the country. This testing solution is the world’s first CRISPR Cas-9 based diagnostic test.
TataMD CHECK will be associated as the Official Healthcare Partner of Jamshedpur FC in the upcoming Indian Super League 2020-21.
On sealing the partnership, Girish Krishnamurthy CEO, Tata Medical and Diagnostic Limited said, “We are delighted to partner with Jamshedpur FC to help create awareness among a growing football fan base about how TataMD CHECK, the latest CRISPR-based testing solutions can help control the pandemic quickly and efficiently and lead us back to resumption of normal lives, including having passionate fans back filling the stadiums. With an exciting team, we hope Jamshedpur FC will set the standard in the ISL this year.”
Commenting on the association, Mukul Choudhari, Chief Executive Officer – Jamshedpur FC, said, “Historically, the Tata group has pioneered and taken the lead during the toughest of periods and they have done it once again during the ongoing global pandemic. TataMD CHECK is an extremely positive development for the world in this difficult battle against COVID-19. We are happy to be a part of this association and we hope to create maximum awareness about this testing solution so that the country can ‘Test with the Best’ with TataMD CHECK.”
As part of the deal, the TataMD CHECK logo will be visible on the Jamshedpur FC jersey along with various other methods to spread awareness. TataMD CHECK, powered by FELUDA, is the world’s first COVID-19 diagnostic test based on the DNA genome editing tool CRISPR Cas-9.